Chief Scientific Officer · Link Cell Therapies · company speakers →
Mark Wallet joined Link Cell Therapies in October 2024 as Chief Scientific Officer. Previously, he was VP and Head of Immuno-oncology at Century Therapeutics, leading preclinical development of gene-edited iPSC-derived CAR-NK and CAR-T cell therapies for cancer. Earlier, at Fate Therapeutics, he built the translational science team advancing allogeneic donor-derived NK and iPSC-derived cell therapies. He began his career as a faculty member at the University of Florida where his lab focused on immunogenetics research in autoimmunity and infectious disease. Mark holds a Ph.D. in Microbiology and Immunology from UNC Chapel Hill.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →